{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:25:22Z","timestamp":1794918322451,"version":"4.9.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["SONATA-17"],"award-info":[{"award-number":["SONATA-17"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["DEC-2021\/43\/D\/ST4\/02311"],"award-info":[{"award-number":["DEC-2021\/43\/D\/ST4\/02311"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.biopha.2025.117967","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T11:08:32Z","timestamp":1741950512000},"page":"117967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Sodium-glucose co-transporters (SGLT2) inhibitors prevent lipid droplets formation in vascular inflammation or lipid overload by SGLT2-independent mechanism"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-0206","authenticated-orcid":false,"given":"Natalia","family":"Chorazy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9884-2032","authenticated-orcid":false,"given":"Kamila","family":"Wojnar-Lason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8241-1185","authenticated-orcid":false,"given":"Anna M.","family":"Gdula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coert J.","family":"Zuurbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Chlopicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0391-2502","authenticated-orcid":false,"given":"Marta Z.","family":"Pacia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117967_bib1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/14789450.2021.1995356","article-title":"Lipid droplets diversity and functions in inflammation and immune response","volume":"18","author":"Pereira-Dutra","year":"2021","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.biopha.2025.117967_bib2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.bbalip.2017.06.006","article-title":"Establishing the lipid droplet proteome: mechanisms of lipid droplet protein targeting and degradation","volume":"1862","author":"Bersuker","year":"2017","journal-title":"Biochim. Biophys. Acta, Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.biopha.2025.117967_bib3","first-page":"1","article-title":"In Close Proximity: the lipid droplet proteome and crosstalk with the endoplasmic reticulum","volume":"1","author":"Bersuker","year":"2018","journal-title":"Contact"},{"key":"10.1016\/j.biopha.2025.117967_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.devcel.2017.11.020","article-title":"A proximity labeling strategy provides insights into the composition and dynamics of lipid droplet proteomes","volume":"44","author":"Bersuker","year":"2018","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biopha.2025.117967_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","article-title":"Dynamics and functions of lipid droplets","volume":"20","author":"Olzmann","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117967_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1083\/jcb.201311051","article-title":"Biogenesis of the multifunctional lipid droplet: lipids, proteins, and sites","volume":"204","author":"Pol","year":"2014","journal-title":"JCB"},{"key":"10.1016\/j.biopha.2025.117967_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.biochi.2019.11.016","article-title":"A twist of FATe: Lipid droplets and inflammatory lipid mediators","volume":"169","author":"Jarc","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2025.117967_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/emmm.201100671","article-title":"Balancing the fat: lipid droplets and human disease","volume":"5","author":"Krahmer","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2025.117967_bib9","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCRESAHA.116.310498","article-title":"Lipid droplet biogenesis and function in the endothelium","volume":"120","author":"Kuo","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.117967_bib10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/ajpcell.00239.2021","article-title":"Adaptive and maladaptive roles of lipid droplets in health and disease","volume":"322","author":"Pressly","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2025.117967_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41574-021-00471-8","article-title":"Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics","volume":"17","author":"Morigny","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2025.117967_bib12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bbalip.2009.01.005","article-title":"Leukocyte lipid bodies\u2014biogenesis and functions in inflammation","volume":"1791","author":"Bozza","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.biopha.2025.117967_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules23081941","article-title":"Lipid droplets in cancer: guardians of fat in a stressful world","volume":"23","author":"Petan","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.117967_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2023.101791","article-title":"Lipid droplets control mitogenic lipid mediator production in human cancer cells","volume":"76","author":"Jovi\u010di\u0107","year":"2023","journal-title":"Mol. Metab."},{"key":"10.1016\/j.biopha.2025.117967_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-52621-x","article-title":"Lipid droplets sequester palmitic acid to disrupt endothelial ciliation and exacerbate atherosclerosis in male mice","volume":"15","author":"Tan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117967_bib16","first-page":"2099","article-title":"Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment","volume":"57","author":"Ertunc","year":"2016","journal-title":"JLR"},{"key":"10.1016\/j.biopha.2025.117967_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbamcr.2020.118681","article-title":"Heterogeneity of chemical composition of lipid droplets in endothelial inflammation and apoptosis","volume":"1867","author":"Pacia","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.biopha.2025.117967_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-022-04362-7","article-title":"Rac1 regulates lipid droplets formation, nanomechanical, and nanostructural changes induced by TNF in vascular endothelium in the isolated murine aorta","volume":"79","author":"Pacia","year":"2022","journal-title":"CMLS"},{"key":"10.1016\/j.biopha.2025.117967_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbadis.2024.167201","article-title":"Vascular inflammation and biogenesis of lipid droplets; what is the link?","volume":"1870","author":"Chorazy","year":"2024","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2025.117967_bib20","first-page":"1","article-title":"Vascular lipid droplets formed in response to TNF, hypoxia, or OA: biochemical composition and prostacyclin generation","volume":"64","author":"Pacia","year":"2023","journal-title":"JLR"},{"key":"10.1016\/j.biopha.2025.117967_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-024-05167-6","article-title":"Vascular ATGL-dependent lipolysis and the activation of cPLA2\u2013PGI2 pathway protect against postprandial endothelial dysfunction","volume":"81","author":"Sternak","year":"2024","journal-title":"CMLS"},{"key":"10.1016\/j.biopha.2025.117967_bib22","first-page":"1","article-title":"Estimation of the content of lipids composing endothelial lipid droplets based on Raman imaging","volume":"1865","author":"Pacia","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.biopha.2025.117967_bib23","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1039\/C4AN01870B","article-title":"Biochemical changes of the endothelium in the murine model of NO-deficient hypertension","volume":"140","author":"Pacia","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.biopha.2025.117967_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nano.2018.11.014","article-title":"Biology, Medicine, Combined Raman-and AFM-based detection of biochemical and nanomechanical features of endothelial dysfunction in aorta isolated from ApoE\/LDLR\u2212\/\u2212 mice","volume":"16","author":"Maase","year":"2019","journal-title":"Nanomed"},{"key":"10.1016\/j.biopha.2025.117967_bib25","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/jrs.4965","article-title":"Rapid biochemical profiling of endothelial dysfunction in diabetes, hypertension and cancer metastasis by hierarchical cluster analysis of Raman spectra","volume":"47","author":"Pacia","year":"2016","journal-title":"J. Raman Spectrosc."},{"key":"10.1016\/j.biopha.2025.117967_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.vibspec.2014.09.004","article-title":"A novel approach to investigate vascular wall in 3D: combined Raman spectroscopy and atomic force microscopy for aorta en face imaging","volume":"75","author":"Pilarczyk","year":"2014","journal-title":"Vib. Spectrosc."},{"key":"10.1016\/j.biopha.2025.117967_bib27","first-page":"3381","article-title":"3D Raman imaging of systemic endothelial dysfunction in the murine model of metastatic breast cancer","volume":"408","author":"Pacia","year":"2016","journal-title":"ABC"},{"key":"10.1016\/j.biopha.2025.117967_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/aps.2011.200","article-title":"Role of G protein-coupled receptors in inflammation","volume":"33","author":"Sun","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2025.117967_bib29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"NEJM"},{"key":"10.1016\/j.biopha.2025.117967_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"NEJM"},{"key":"10.1016\/j.biopha.2025.117967_bib31","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"NEJM"},{"key":"10.1016\/j.biopha.2025.117967_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.120.016270","article-title":"Molecular, cellular, and clinical evidence that sodium-glucose cotransporter 2 inhibitors act as neurohormonal antagonists when used for the treatment of chronic heart failure","volume":"9","author":"Packer","year":"2020","journal-title":"JAHA"},{"key":"10.1016\/j.biopha.2025.117967_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2021.112515","article-title":"Empagliflozin reduces oxidative stress through inhibition of the novel inflammation\/NHE\/[Na+\u2009] c\/ROS-pathway in human endothelial cells","volume":"146","author":"Uthman","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.117967_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox10081228","article-title":"Does empagliflozin modulate leukocyte\u2013endothelium interactions, oxidative stress, and inflammation in type 2 diabetes?","volume":"10","author":"Canet","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2025.117967_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2020.173040","article-title":"Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice","volume":"875","author":"Ganbaatar","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117967_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2020.104781","article-title":"Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium","volume":"157","author":"Cappetta","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2025.117967_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11010-019-03555-2","article-title":"Empagliflozin restores the integrity of the endothelial glycocalyx in vitro","volume":"459","author":"Cooper","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2025.117967_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/1479164117733626","article-title":"Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: a potential mechanism for inhibition of atherogenesis","volume":"15","author":"Gaspari","year":"2018","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"10.1016\/j.biopha.2025.117967_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13105-023-00974-0","article-title":"The SGLT2 inhibitor empagliflozin attenuates atherosclerosis progression by inducing autophagy","volume":"80","author":"Xu","year":"2024","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2025.117967_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2019.113677","article-title":"Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats","volume":"170","author":"Aragon-Herrera","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117967_bib41","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na+\u2009through inhibition of the cardiac Na+\u2009\/H+\u2009exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2025.117967_bib42","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","article-title":"Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+\u2009\/H+\u2009exchanger, lowering of cytosolic Na+\u2009and vasodilation","volume":"61","author":"Uthman","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2025.117967_bib43","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/cvr\/cvab129","article-title":"SGLT2 inhibitor empagliflozin inhibits the cardiac Na+\u2009\/H+\u2009exchanger 1: persistent inhibition under various experimental conditions","volume":"117","author":"Zuurbier","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2025.117967_bib44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/CIRCULATIONAHA.122.061688","article-title":"Sodium glucose cotransporter-2 inhibitor empagliflozin reduces infarct size independently of sodium glucose cotransporter-2","volume":"147","author":"Chen","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.117967_bib45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00395-024-01067-9","article-title":"Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2","volume":"119","author":"Chen","year":"2024","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.biopha.2025.117967_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.amjhyper.2006.05.022","article-title":"Epithelial sodium channel inhibition in cardiovascular disease: a potential role for amiloride","volume":"20","author":"Teiwes","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.biopha.2025.117967_bib47","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2337\/dc18-0588","article-title":"SGLT2 inhibitors in combination therapy: from mechanisms to clinical considerations in type 2 diabetes management","volume":"41","author":"van Baar","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2025.117967_bib48","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/ajh\/hpae092","article-title":"State-of-the-art-review: mechanisms of action of SGLT2 inhibitors and clinical implications","volume":"37","author":"Vallon","year":"2024","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.biopha.2025.117967_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10061403","article-title":"Lipid droplets formation represents an integral component of endothelial inflammation induced by LPS","volume":"10","author":"Czamara","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.117967_bib50","first-page":"1","article-title":"Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.biopha.2025.117967_bib51","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCRESAHA.124.324823","article-title":"SGLT2 inhibitors act independently of SGLT2 to confer benefit for HFrEF in mice","volume":"135","author":"Berger","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.117967_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-94-007-6211-4_6","article-title":"Formation and function of lipid droplets in inflammation and cancer","author":"Viola","year":"2013","journal-title":"Trends Stem Cell Prolif. Cancer Res."},{"key":"10.1016\/j.biopha.2025.117967_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175560","article-title":"Dapagliflozin ameliorates diabetic renal injury through suppressing the self-perpetuating cycle of inflammation mediated by HMGB1 feedback signaling in the kidney","volume":"943","author":"Yuan","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117967_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0054442","article-title":"Effects of SGLT2 inhibition in human kidney proximal tubular cells\u2014renoprotection in diabetic nephropathy?","volume":"8","author":"Panchapakesan","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2025.117967_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10061457","article-title":"Dapagliflozin restores impaired autophagy and suppresses inflammation in high glucose-treated HK-2 cells","volume":"10","author":"Xu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.117967_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2020.588664","article-title":"Sodium transporters in human health and disease","volume":"11","author":"Gagnon","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2025.117967_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2023.102979","article-title":"Empagliflozin prevents oxidative stress in human coronary artery endothelial cells via the NHE\/PKC\/NOX axis","volume":"69","author":"Li","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.117967_bib58","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/ajplung.2000.278.6.L1107","article-title":"Protein kinase C-\u03b1 mediates endothelial barrier dysfunction induced by TNF-\u03b1","volume":"278","author":"Ferro","year":"2000","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.biopha.2025.117967_bib59","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1196\/annals.1420.016","article-title":"Regulation of endothelial junctional permeability","volume":"1123","author":"Vandenbroucke","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.117967_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2021.680775","article-title":"Inhibition of Rac1 GTPase decreases vascular oxidative stress, improves endothelial function, and attenuates atherosclerosis development in mice","volume":"8","author":"Zimmer","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2025.117967_bib61","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db16-0058","article-title":"The Na+\u2009\/glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels","volume":"65","author":"Hawley","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.117967_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-23420-4","article-title":"Canagliflozin inhibits interleukin-1\u03b2-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and-independent mechanisms","volume":"8","author":"Mancini","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117967_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2023.114907","article-title":"Canagliflozin mitigates carfilzomib-induced endothelial apoptosis via an AMPK-dependent pathway","volume":"164","author":"Dabour","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.117967_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2023.1145111","article-title":"Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders","volume":"14","author":"Maiorana","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2025.117967_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11010-021-04260-9","article-title":"Modulation of endothelium function by fatty acids","volume":"477","author":"Mallick","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2025.117967_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2019.110539","article-title":"Empaglifozin mitigates NAFLD in high-fat-fed mice by alleviating insulin resistance, lipogenesis and ER stress","volume":"498","author":"Petito-da-Silva","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2025.117967_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2024.1393946","article-title":"Empagliflozin alters lipid metabolism in the myocardium and liver in a prediabetes model with severe dyslipidemia","volume":"15","author":"Miklankova","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117967_bib68","doi-asserted-by":"crossref","first-page":"865","DOI":"10.33594\/000000178","article-title":"Empagliflozin and dapagliflozin reduce ROS generation and restore NO bioavailability in tumor necrosis factor \u03b1-stimulated human coronary arterial endothelial cells","volume":"53","author":"Uthman","year":"2019","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.biopha.2025.117967_bib69","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1111\/bph.15850","article-title":"Amelioration of endothelial dysfunction by sodium glucose co-transporter 2 inhibitors: pieces of the puzzle explaining their cardiovascular protection","volume":"179","author":"Li","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117967_bib70","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0223-5234(03)00100-4","article-title":"D. Laeckmann, An overview of inhibitors of Na+\u2009\/H+\u2009exchanger","volume":"38","author":"Masereel","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.117967_bib71","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2007.03.056","article-title":"Pharmacodynamic characteristics and cardioprotective effects of new NHE1 inhibitors","volume":"567","author":"Kim","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117967_bib72","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1093\/cvr\/cvaa323","article-title":"Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+\u2009\/H+\u2009exchanger-1 or lower [Na+\u2009] i in the heart","volume":"117","author":"Chung","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2025.117967_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab724.0725","article-title":"Empagliflozin reduces TNFa-induced reactive oxygen species through inhibition of the human endothelial Na+\u2009\/H+\u2009exchanger 1","volume":"42","author":"Uthman","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2025.117967_bib74","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1113\/jphysiol.2011.227132","article-title":"NHE1 knockout reduces blood pressure and arterial media\/lumen ratio with no effect on resting pHi in the vascular wall","volume":"590","author":"Boedtkjer","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2025.117967_bib75","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1164\/rccm.200710-1522OC","article-title":"Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling","volume":"177","author":"Yu","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2025.117967_bib76","first-page":"33","article-title":"Loss of NHE1 activity leads to reduced oxidative stress in heart and mitigates high-fat diet-induced myocardial stress","volume":"65","author":"Prasad","year":"2013","journal-title":"JMCC"},{"key":"10.1016\/j.biopha.2025.117967_bib77","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1152\/ajpcell.1999.276.4.C788","article-title":"Targeted disruption of the murine Nhe1 locus induces ataxia, growth retardation, and seizures","volume":"276","author":"Bell","year":"1999","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2025.117967_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2024.177147","article-title":"Empagliflozin prevents TNF-\u03b1 induced endothelial dysfunction under flow-the potential involvement of calcium and sodium-hydrogen exchanger","volume":"986","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:22:32Z","timestamp":1778541752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":78,"alternative-id":["S0753332225001611"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117967","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-glucose co-transporters (SGLT2) inhibitors prevent lipid droplets formation in vascular inflammation or lipid overload by SGLT2-independent mechanism","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117967"}}